Insider Trading activities at Akero Therapeutics, Inc. (AKRO) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akero Therapeutics, Inc. (AKRO) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Akero Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1744659.

Total stock buying since 2019: $122,639,119.
Total stock sales since 2019: $244,965,606.
Total stock option exercises since 2019: $26,916,135.


 1   2   3 
19 insiders reported insider trading activities at Akero Therapeutics, Inc. (AKRO):
Insider trading activities of Goodman Corey S
Insider trading activities of Lamy Patrick
Insider trading activities of Bitterman Kevin
Insider trading activities of Atp Iii Gp, Ltd.
Insider trading activities of Henderson Jane
Insider trading activities of Gangloff Scott A.
Insider trading activities of Harrison Seth Loring
Insider trading activities of Montrago Trustees Ltd
Insider trading activities of Atlas Venture Opportunity Fund I, L.p.
Insider trading activities of Young Jonathan
Insider trading activities of Heyman Tomas J.
Insider trading activities of Versant Venture Capital Vi, L.p.
Insider trading activities of Cheng Andrew
Insider trading activities of Rolph Timothy
Insider trading activities of Royston Aaron
Insider trading activities of Yale Catriona
Insider trading activities of White William Richard
Insider trading activities of Graham G. Walmsley
Insider trading activities of Versant Ventures Vi Gp-gp, Llc

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Akero Therapeutics, Inc. (AKRO).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 400,000 $18,387,920 783,368 $38,925,730 528,475 $8,859,234
2024 0 $0 903,699 $26,910,701 818,995 $12,138,327
2023 800,000 $22,531,199 638,727 $30,054,552 612,127 $2,283,186
2022 0 $0 2,521,334 $105,229,431 485,960 $2,866,368
2021 0 $0 333,324 $8,097,709 126,500 $653,302
2020 830,000 $29,880,000 1,109,902 $24,743,439 120,196 $115,718
2019 3,240,000 $51,840,000 462,597 $11,004,044 0 $0


Table 3. Detailed insider trading at Akero Therapeutics, Inc. (AKRO) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-01-14 White William Richard (Chief Financial Officer) Option Ex 9,700 7.01 67,987
2022-01-10 Cheng Andrew (President & CEO) Option Ex 10,000 .61 6,150
2022-01-07 Young Jonathan (Chief Operating Officer) Option Ex 27,744 .61 17,062
2022-01-03 Cheng Andrew (President & CEO) Option Ex 53,000 .61 32,595
2021-12-21 White William Richard (Chief Financial Officer) Sale 100 22.00 2,200
2021-12-21 White William Richard (Chief Financial Officer) Option Ex 100 7.01 700
2021-12-17 White William Richard (Chief Financial Officer) Sale 3,200 22.04 70,528
2021-12-17 White William Richard (Chief Financial Officer) Option Ex 3,200 7.01 22,428
2021-12-02 Cheng Andrew (President & CEO) Sale 17,500 20.18 353,150
2021-11-04 Young Jonathan (Chief Operating Officer) Sale 6,220 24.33 151,332
2021-11-03 Young Jonathan (Chief Operating Officer) Sale 18,780 24.27 455,790
2021-11-02 Cheng Andrew (President & CEO) Sale 17,500 22.57 394,975
2021-11-01 White William Richard (Chief Financial Officer) Sale 6,500 22.24 144,560
2021-11-01 White William Richard (Chief Financial Officer) Option Ex 6,500 7.01 45,558
2021-10-15 Yale Catriona (Chief Development Officer) Sale 12,500 21.96 274,500
2021-10-04 Cheng Andrew (President & CEO) Sale 17,500 21.54 376,950
2021-10-01 White William Richard (Chief Financial Officer) Sale 6,500 22.06 143,364
2021-10-01 White William Richard (Chief Financial Officer) Option Ex 6,500 7.01 45,558
2021-09-15 Yale Catriona (Chief Development Officer) Sale 12,500 24.94 311,750
2021-09-02 Cheng Andrew (President & CEO) Sale 17,500 23.89 418,075
2021-09-01 Young Jonathan (Chief Operating Officer) Sale 12,500 24.04 300,500
2021-09-01 White William Richard (Chief Financial Officer) Sale 8,559 24.00 205,416
2021-09-01 White William Richard (Chief Financial Officer) Option Ex 8,559 7.01 59,990
2021-08-16 Yale Catriona (Chief Development Officer) Sale 10,000 18.79 187,900
2021-08-03 Cheng Andrew (President & CEO) Sale 17,500 21.14 370,037
2021-08-02 White William Richard (Chief Financial Officer) Sale 4,441 22.03 97,835
2021-08-02 White William Richard (Chief Financial Officer) Option Ex 4,441 7.01 31,126
2021-07-15 Young Jonathan (Chief Operating Officer) Option Ex 9,000 .61 5,535
2021-07-15 Yale Catriona (Chief Development Officer) Sale 10,000 20.90 209,040
2021-07-06 White William Richard (Chief Financial Officer) Sale 6,500 24.52 159,380
2021-07-06 White William Richard (Chief Financial Officer) Option Ex 6,500 7.01 45,558
2021-07-02 Cheng Andrew (President & CEO) Sale 17,500 24.78 433,650
2021-06-01 Young Jonathan (Chief Operating Officer) Sale 3,055 26.24 80,150
2021-06-01 Bitterman Kevin (Director) Sale 17,489 26.28 459,610
2021-05-03 Young Jonathan (Chief Operating Officer) Sale 3,055 30.56 93,360
2021-05-03 White William Richard (Chief Financial Officer) Sale 4,200 30.56 128,352
2021-05-03 White William Richard (Chief Financial Officer) Option Ex 4,200 7.01 29,437
2021-04-01 Young Jonathan (Chief Operating Officer) Sale 3,055 28.75 87,828
2021-04-01 White William Richard (Chief Financial Officer) Sale 50,000 28.96 1,447,950
2021-04-01 White William Richard (Chief Financial Officer) Option Ex 50,000 7.01 350,500
2021-03-01 Young Jonathan (Chief Operating Officer) Sale 3,055 30.80 94,094
2021-02-01 Young Jonathan (Chief Operating Officer) Sale 3,055 29.55 90,290
2021-01-10 Cheng Andrew (President & CEO) Sale 10,000 19.55 195,500
2021-01-08 Young Jonathan (Chief Operating Officer) Sale 10,000 28.12 281,200
2021-01-07 Young Jonathan (Chief Operating Officer) Option Ex 7,500 .61 4,612
2021-01-07 Cheng Andrew (President & CEO) Option Ex 20,000 .61 12,300
2021-01-04 Young Jonathan (Chief Operating Officer) Sale 3,060 25.64 78,443
2020-12-28 Cheng Andrew (President & CEO) Option Ex 7,480 .62 4,637
2020-12-21 Cheng Andrew (President & CEO) Option Ex 10,500 .62 6,510
2020-10-09 Bitterman Kevin (Director) Sale 13,000 28.93 376,090
2020-07-10 Atp Iii Gp, Ltd. (10% Owner) Buy 415,000 36.00 14,940,000
2020-07-10 Harrison Seth Loring (Director) Buy 415,000 36.00 14,940,000
2020-07-06 Goodman Corey S Sale 4,603 33.83 155,719
2020-07-02 Goodman Corey S Sale 3,800 33.63 127,805
2020-07-01 Goodman Corey S Sale 108,064 34.45 3,723,020
2020-03-30 Graham G. Walmsley (Director) Option Ex 2,168 19.97 43,294
2020-03-13 Young Jonathan (Chief Operating Officer) Option Ex 11,117 .61 6,836
2020-03-12 Rolph Timothy (Chief Scientific Officer) Option Ex 50,024 .61 30,514
2020-03-03 Goodman Corey S (10% Owner) Sale 6,401 23.00 147,197
2020-03-02 Goodman Corey S (10% Owner) Sale 10,297 23.06 237,459
2020-02-28 Goodman Corey S (10% Owner) Sale 5,100 21.30 108,650
2020-02-27 Goodman Corey S (10% Owner) Sale 1,781 22.54 40,143
2020-02-26 Goodman Corey S (10% Owner) Sale 2,523 22.44 56,616
2020-02-25 Goodman Corey S (10% Owner) Sale 1,600 23.67 37,876
2020-02-12 Goodman Corey S (10% Owner) Sale 6 27.14 162
2020-02-11 Goodman Corey S (10% Owner) Sale 2,184 27.05 59,068
2020-02-10 Goodman Corey S (10% Owner) Sale 7,836 27.08 212,167
2020-02-06 Goodman Corey S (10% Owner) Sale 6,102 27.03 164,955
2020-02-05 Goodman Corey S (10% Owner) Sale 28,608 25.99 743,550
2020-02-04 Goodman Corey S (10% Owner) Sale 53,731 25.65 1,378,200
2020-01-21 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 25,940 22.09 572,884
2020-01-17 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 11,103 20.09 223,059
2020-01-16 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 22,489 19.72 443,483
2020-01-15 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 7,511 19.73 148,192
2020-01-14 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 12,307 20.00 246,140
2020-01-13 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 11,676 20.50 239,358
2020-01-13 Goodman Corey S (10% Owner) Sale 494,000 20.23 9,993,620
2020-01-10 Young Jonathan (Chief Operating Officer) Option Ex 38,907 .61 23,927
2020-01-10 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 19,343 20.10 388,794
2020-01-09 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 16,527 20.21 334,010
2020-01-08 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 22,368 19.80 442,886
2020-01-08 Goodman Corey S (10% Owner) Sale 15,677 19.86 311,360
2020-01-07 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 14,162 20.05 283,948
2020-01-07 Goodman Corey S (10% Owner) Sale 31,000 20.17 625,146
2020-01-06 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 53,392 18.64 995,387
2020-01-06 Goodman Corey S (10% Owner) Sale 42,221 19.64 829,389
2020-01-03 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 3,200 19.73 63,120
2020-01-03 Goodman Corey S (10% Owner) Sale 12,498 19.30 241,211
2020-01-02 Versant Ventures Vi Gp-gp, Llc (10% Owner) Sale 15,852 21.09 334,271
2020-01-02 Goodman Corey S (10% Owner) Sale 23,000 19.93 458,504
2019-12-31 Versant Venture Capital Vi, L.p. (10% Owner) Sale 17,207 23.48 404,020
2019-12-31 Goodman Corey S (10% Owner) Sale 14,324 23.96 343,260
2019-12-30 Versant Venture Capital Vi, L.p. (10% Owner) Sale 338,919 24.39 8,266,234
2019-12-27 Versant Venture Capital Vi, L.p. (10% Owner) Sale 33,256 22.58 750,920
2019-12-26 Versant Venture Capital Vi, L.p. (10% Owner) Sale 23,600 22.48 530,528
2019-12-24 Versant Venture Capital Vi, L.p. (10% Owner) Sale 1,605 21.70 34,828
2019-12-23 Versant Venture Capital Vi, L.p. (10% Owner) Sale 5,433 21.56 117,135
2019-12-20 Versant Venture Capital Vi, L.p. (10% Owner) Sale 18,582 19.80 367,923
2019-12-18 Versant Venture Capital Vi, L.p. (10% Owner) Sale 2,020 19.50 39,390
2019-12-17 Versant Venture Capital Vi, L.p. (10% Owner) Sale 7,651 19.58 149,806
2019-06-24 Atlas Venture Opportunity Fund I, L.p. (10% Owner) Buy 270,000 16.00 4,320,000
2019-06-24 Royston Aaron (Director) Buy 250,000 16.00 4,000,000
2019-06-24 Versant Venture Capital Vi, L.p. (10% Owner) Buy 400,000 16.00 6,400,000
2019-06-24 Atp Iii Gp, Ltd. (10% Owner) Buy 900,000 16.00 14,400,000
2019-06-24 Bitterman Kevin (Director) Buy 270,000 16.00 4,320,000
2019-06-24 Harrison Seth Loring (Director) Buy 900,000 16.00 14,400,000
2019-06-24 Goodman Corey S (10% Owner) Buy 250,000 16.00 4,000,000
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of AKRO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Akero Therapeutics, Inc. (symbol AKRO, CIK number 1744659) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.